Light as an Aid for Recovery in Psychiatric Inpatients

Sponsor
University of Aarhus (Other)
Overall Status
Completed
CT.gov ID
NCT02653040
Collaborator
Aarhus University Hospital (Other)
54
1
2
27
2

Study Details

Study Description

Brief Summary

The purpose of this pilot study is to evaluate wether a naturalistic indoor light environment can improve sleep and mood in psychiatric inpatients

Condition or Disease Intervention/Treatment Phase
  • Other: Dynamic lighting
N/A

Detailed Description

Setting: 17 bed inpatient ward at a University Mental Health Hospital

Rooms: The dimensions of all 17 rooms are identical with 4,54m x 3,14m, ceiling height 3,15m, a window, a bed, a table, a chair and a bathroom 1,55m x 1,85m.

Assignment of interventions: After admission patients are invited to participate in the study. If the patients wish to participate they will go through eligibility screen, sign informed consent and fill out questionnaires on sleep, mood and well-being (-t1). The patients (now participants) are randomly allocated (t0) by sealed envelope technique and the envelope is brought to the staff office and opened by a staff member who then from the computer in the office programs the participant's room to either intervention or control.

Randomization: The investigators used random permuted blocks of varying and blinded block size. A third party person created the envelopes and arranged them in blocks.

Blinding: The outcome assessor and data analyst is blinded to allocation. Trial participants and care providers are unblinded. Participants may be replaced to another room for practical, clinical reasons. In this case, the intervention/control conditions will follow the patient.

Data management: All data will be entered in RedCAP and stored in a electronic online secured database at Aarhus University.

Power estimation: Alfa: 0.05. Beta: 0.20. Effect size: change of 4 points in PSQI with a standard deviation estimated to 4. Number of patients in each arm: 17 (x 2 = 34). Number needed to be included accounting for discontinuation: 60 (estimated)

Statistics: The investigators will calculate intention-to-treat. Other statistical analyses will include logistic regression for dichotomous outcome data, analysis of covariance for continuous outcome data, and survival analysis for time-to-event outcome data. Interim-analyses during the data-collection period to stop trial if intervention produces larger than expected benefits or harm or if investigators find evidence of no important difference between experimental and control interventions.

Study Design

Study Type:
Interventional
Actual Enrollment :
54 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Light as an Aid for Recovery in Psychiatric Inpatients: A Pragmatic Randomized Controlled Pilot Trial
Actual Study Start Date :
Dec 15, 2015
Actual Primary Completion Date :
Jan 15, 2017
Actual Study Completion Date :
Mar 15, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Dynamic lighting

Indoor lighting with low-lux no-blue wavelengths at night.

Other: Dynamic lighting
Intervention is rooms with light settings imitating natural light conditions with white light at day and low-lux no-blue light at night: 07am-10am: white light, increasing intensity 10am-07pm: white light, full intensity 07pm-11pm: no blue wavelength, low intensity 11pm-07am: no blue wavelength, very low intensity
Other Names:
  • Illumination, lighting design, lighting environment
  • No Intervention: Treatment as usual

    Characterized by full white light with little variation through a day cyclus.

    Outcome Measures

    Primary Outcome Measures

    1. Sleep quality on the Pittsburgh Sleep Quality Index (PSQI) [Answers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months]

    Secondary Outcome Measures

    1. Depressive symptoms on the Major depression inventory (MDI) [Answers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months]

    2. Well-being on the World Health Organization measure of well-being (WHO-5) [Answers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months]

    3. Qualitative assessment using a custom made questionnaire [Answers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months]

      Number of patients with side-effects.

    4. Sleep diary [Answers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months]

    Other Outcome Measures

    1. Time to discharge [Assessed through study completion, an average of 1 month, up to 6 months]

      Number of days between admission and discharge

    2. Involuntary restraints [Assessed through study completion, an average of 1 month, up to 6 months]

      Number of participants who experienced involuntary physical and/or medical restraints.

    3. Use of medication from logged activity in the electronic medical record [Assessed through study completion, an average of 1 month, up to 6 months]

      Use of medication during admission including drug og dosages administered to the participants in mg/day.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 68 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Admission
    Exclusion Criteria:
    • Inability to provide written consent

    • Mania

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Affective Disorders, Aarhus University Hospital, Risskov Risskov Jylland Denmark 8240

    Sponsors and Collaborators

    • University of Aarhus
    • Aarhus University Hospital

    Investigators

    • Principal Investigator: Niels Okkels, MD, Aarhus University Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    University of Aarhus
    ClinicalTrials.gov Identifier:
    NCT02653040
    Other Study ID Numbers:
    • QLIGHT
    First Posted:
    Jan 12, 2016
    Last Update Posted:
    May 3, 2018
    Last Verified:
    Oct 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Keywords provided by University of Aarhus
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 3, 2018